| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 7.076 | 110.568 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 7.076 | 110.568 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 1.403 | 53.381 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 5.673 | 57.187 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 5.602 | 54.955 |
| Employees | - | - | - | - | - | - | - | - | 1 | 1 |
Check the financial reports for the company - Mexamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 0 | 15.344 |
| Current Assets | - | - | - | - | - | - | - | - | 7.084 | 50.163 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | - | 6.172 | 38.196 |
| Cash | - | - | - | - | - | - | - | - | 911 | 11.967 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 5.643 | 60.567 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 1.441 | 4.940 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mexamed S.r.l.